Pioneering the Molecular Frontier

Wild Boar Biosciences specializes in developing peptide mimetics for targeted drug discovery. Our research focuses on mechanism-driven therapeutics that address inflammation-related disorders with high precision and safety. We apply the same scientific principles to enzyme development for bioremediation projects. 

 We concentrate on indications where our peptide and capabilities can deliver clear clinical and partnering value. In parallel, our bioremediation concepts demonstrate how our platform can address industrial and environmental challenges, with design and process choices evaluated for speed, cost, and environmental impact.

At Wild Boar Biosciences, we foster a culture of creativity, collaboration, and excellence. Teams are expected to think end-to-end, from target biology through manufacturability, environmental footprint, and longer-term enzyme-driven concepts. We build assets that are scientifically compelling today and create credible options in adjacent sustainability markets tomorrow.